Upon completion of this session, participants should be able to:
- identify biologic agents in use for the treatment of rheumatoid arthritis
- describe the risk/benefit profiles of biologic agents
- discuss the emerging biologics and their advantages for the therapeutic algorithm
To see other sessions for this day, use the date buttons to the left.